A Phase II Clinical Trial of Endoscopic Submucosal Dissection for Early Gastric Cancer of Undifferentiated Type: Japan Clinical Oncology Group Study JCOG1009/1010
Authors:
- Kohei TakizawaKTKohei Takizawa
- for the Gastrointestinal Endoscopy Study Group (GIESG) and Stomach Cancer Study Group (SCSG) of the Japan Clinical Oncology Group (JCOG)F(for the Gastrointestinal Endoscopy Study Group (GIESG) and Stomach Cancer Study Group (SCSG) of the Japan Clinical Oncology Group (JCOG)
Open Access
- 19 November 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 43 (1) , 87-91
Abstract
A Phase II clinical trial has been initiated to evaluate the efficacy and safety of endoscopic submucosal dissection for intramucosal (cT1a) gastric cancer of undifferentiated type. Patients with cT1a gastric cancer with undifferentiated-type adenocarcinoma are eligible for the study. The tumor size should be 2 cm or less without ulceration. The study will enroll a total of 325 patients from 51 institutions over a 4-year period. The primary endpoint is proportion of 5-year overall survival (% 5-year overall survival) in patients with undifferentiated dominant type. The secondary endpoints are overall survival, relapse-free survival, distant metastasis-free survival, % 5-year overall survival without either recurrence or gastrectomy, % en-bloc resection with endoscopic submucosal dissection, % pathological curative resection with endoscopic submucosal dissection, % 5-year overall survival in patients with differentiated dominant type, % 5-year overall survival in patients with pathologically curative resection with endoscopic submucosal dissection and adverse events. This trial was registered at the UMIN Clinical Trials Registry as UMIN000004995.Keywords
This publication has 7 references indexed in Scilit:
- THERAPEUTIC OUTCOMES OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF UNDIFFERENTIATED‐TYPE INTRAMUCOSAL GASTRIC CANCER WITHOUT ULCERATION AND PREOPERATIVELY DIAGNOSED AS 20 MILLIMETRES OR LESS IN DIAMETERDigestive Endoscopy, 2010
- Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancerGastric Cancer, 2009
- A Phase II Trial of Endoscopic Submucosal Dissection for Mucosal Gastric Cancer: Japan Clinical Oncology Group Study JCOG0607Japanese Journal of Clinical Oncology, 2009
- Gastric cancer treated in 1991 in Japan: data analysis of nationwide registryGastric Cancer, 2006
- ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY GASTRIC CANCER: TECHNICAL FEASIBILITY, OPERATION TIME AND COMPLICATIONS FROM A LARGE CONSECUTIVE SERIESDigestive Endoscopy, 2004
- Endoscopic mucosal resection for treatment of early gastric cancerGut, 2001
- Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centersGastric Cancer, 2000